Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 53M | 19.8% |
| Gross Profit | 31M | 25.8% |
| Cost of Revenue | 22M | 12.1% |
| Operating expense | 58M | 10.7% |
| Net Income | -26M | 1.3% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 374M | 2.2% |
| Total Liabilities | 123M | 3.1% |
| Total Equity | 252M | 4.6% |
| Shares Outstanding | 52M | 1% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -16M | 51.3% |
| Cash from investing | -1M | 46.4% |
| Cash from financing | 5.3M | 104.8% |
EPS
Financial Highlights for PROCEPT BioRobotics in Q2 '24
PROCEPT BioRobotics reported a revenue of 53M, which is a 19.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 31M, marking a 25.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 22M, a 12.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 58M, showing a 10.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -26M, showing a 1.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
It was a positive quarter for PROCEPT BioRobotics with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
